a novel therapeutic strategy for the treatment of glioma, combining chemical and molecular targeting of hsp90a一种新型治疗脑胶质瘤的治疗策略,结合hsp90a的化学和分子定位.pdfVIP

a novel therapeutic strategy for the treatment of glioma, combining chemical and molecular targeting of hsp90a一种新型治疗脑胶质瘤的治疗策略,结合hsp90a的化学和分子定位.pdf

  1. 1、本文档共17页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  5. 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  6. 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  7. 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  8. 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
a novel therapeutic strategy for the treatment of glioma, combining chemical and molecular targeting of hsp90a一种新型治疗脑胶质瘤的治疗策略,结合hsp90a的化学和分子定位

Cancers 2011, 3, 4228-4244; doi:10.3390/cancers3044228 OPEN ACCESS cancers ISSN 2072-6694 /journal/cancers Article A Novel Therapeutic Strategy for the Treatment of Glioma, Combining Chemical and Molecular Targeting of Hsp90 Adi Mehta, Leroy Shervington, Chinmay Munje and Amal Shervington * Brain Tumour North West, Faculty of Science and Technology, University of Central Lancashire, Preston, PR1 2HE, UK; E-Mails: abmehta@uclan.ac.uk (A.M.); lashervington@uclan.ac.uk (L.S.); crmunje@uclan.ac.uk (C.M.) * Author to whom correspondence should be addressed; E-Mail: aashervington@; Tel.: +44-0-1772893519; Fax: +44-0-1772892929. Received: 21 October 2011; in revised form: 21 November 2011 / Accepted: 30 November 2011 / Published: 8 December 2011 Abstract: Hsp90’s vital role in tumour survival and progression, together with its highly inducible expression profile in gliomas and its absence in normal tissue and cell lines validates it as a therapeutic target for glioma. Hsp90 was downregulated using the post-transcriptional RNAi strategy (sihsp90) and a post-translational inhibitor, the benzoquinone antibiotic 17-AAG. Glioblastoma U87-MG and normal human astrocyte SVGp12 were treated with sihsp90, 17-AAG and concurrent sihsp90/17-AAG (combined treatment). Both Hsp90 gene silencing and the protein inhibitor approaches resulted in a dramati

您可能关注的文档

文档评论(0)

118zhuanqian + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档